117 related articles for article (PubMed ID: 28785242)
1. Activating Transcription Factor-5 Knockdown Reduces Aggressiveness of Mammary Tumor Cells and Attenuates Mammary Tumor Growth.
Ben-Shmuel S; Rashed R; Rostoker R; Isakov E; Shen-Orr Z; LeRoith D
Front Endocrinol (Lausanne); 2017; 8():173. PubMed ID: 28785242
[TBL] [Abstract][Full Text] [Related]
2. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
3. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract][Full Text] [Related]
4. miR-141-3p functions as a tumor suppressor modulating activating transcription factor 5 in glioma.
Wang M; Hu M; Li Z; Qian D; Wang B; Liu DX
Biochem Biophys Res Commun; 2017 Sep; 490(4):1260-1267. PubMed ID: 28595907
[TBL] [Abstract][Full Text] [Related]
5. Role of ATF5 in the invasive potential of diverse human cancer cell lines.
Nukuda A; Endoh H; Yasuda M; Mizutani T; Kawabata K; Haga H
Biochem Biophys Res Commun; 2016 Jun; 474(3):509-514. PubMed ID: 27125458
[TBL] [Abstract][Full Text] [Related]
6. Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance.
Banerjee D; Boboila S; Okochi S; Angelastro JM; Kadenhe-Chiweshe AV; Lopez G; Califano A; Connolly EP; Greene LA; Yamashiro DJ
Cancer Res Commun; 2023 Dec; 3(12):2518-2530. PubMed ID: 38014922
[TBL] [Abstract][Full Text] [Related]
7. Highly specific role of the insulin receptor in breast cancer progression.
Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
[TBL] [Abstract][Full Text] [Related]
8. Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.
Angelastro JM; Canoll PD; Kuo J; Weicker M; Costa A; Bruce JN; Greene LA
Oncogene; 2006 Feb; 25(6):907-16. PubMed ID: 16170340
[TBL] [Abstract][Full Text] [Related]
9. The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines.
Monaco SE; Angelastro JM; Szabolcs M; Greene LA
Int J Cancer; 2007 May; 120(9):1883-90. PubMed ID: 17266024
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer.
Sears TK; Angelastro JM
Oncotarget; 2017 Oct; 8(48):84595-84609. PubMed ID: 29137451
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of two activating transcription factor 5 isoforms in papillary thyroid carcinoma.
Vicari L; La Rosa C; Forte S; Calabrese G; Colarossi C; Aiello E; Salluzzo S; Memeo L
Onco Targets Ther; 2016; 9():6225-6231. PubMed ID: 27785070
[TBL] [Abstract][Full Text] [Related]
13. CD24(+) cells fuel rapid tumor growth and display high metastatic capacity.
Rostoker R; Abelson S; Genkin I; Ben-Shmuel S; Sachidanandam R; Scheinman EJ; Bitton-Worms K; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Breast Cancer Res; 2015 Jun; 17(1):78. PubMed ID: 26040280
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the human CHOP gene promoter by the stress response transcription factor ATF5 via the AARE1 site in human hepatoma HepG2 cells.
Yamazaki T; Ohmi A; Kurumaya H; Kato K; Abe T; Yamamoto H; Nakanishi N; Okuyama R; Umemura M; Kaise T; Watanabe R; Okawa Y; Takahashi S; Takahashi Y
Life Sci; 2010 Aug; 87(9-10):294-301. PubMed ID: 20654631
[TBL] [Abstract][Full Text] [Related]
15. Interference with ATF5 function enhances the sensitivity of human pancreatic cancer cells to paclitaxel-induced apoptosis.
Hu M; Wang B; Qian D; Li L; Zhang L; Song X; Liu DX
Anticancer Res; 2012 Oct; 32(10):4385-94. PubMed ID: 23060563
[TBL] [Abstract][Full Text] [Related]
16. ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.
Pascual M; Gómez-Lechón MJ; Castell JV; Jover R
Drug Metab Dispos; 2008 Jun; 36(6):1063-72. PubMed ID: 18332083
[TBL] [Abstract][Full Text] [Related]
17. Fasting induced up-regulation of activating transcription factor 5 in mouse liver.
Shimizu YI; Morita M; Ohmi A; Aoyagi S; Ebihara H; Tonaki D; Horino Y; Iijima M; Hirose H; Takahashi S; Takahashi Y
Life Sci; 2009 Jun; 84(25-26):894-902. PubMed ID: 19376136
[TBL] [Abstract][Full Text] [Related]
18. Advancements in Activating Transcription Factor 5 Function in Regulating Cell Stress and Survival.
Paerhati P; Liu J; Jin Z; Jakoš T; Zhu S; Qian L; Zhu J; Yuan Y
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806136
[TBL] [Abstract][Full Text] [Related]
19. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
20. Protective neuronal induction of ATF5 in endoplasmic reticulum stress induced by status epilepticus.
Torres-Peraza JF; Engel T; Martín-Ibáñez R; Sanz-Rodríguez A; Fernández-Fernández MR; Esgleas M; Canals JM; Henshall DC; Lucas JJ
Brain; 2013 Apr; 136(Pt 4):1161-76. PubMed ID: 23518711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
